The leading rheumatology resource
for patients and physicians.

Commencez à lire en

Herpes Zoster Vaccination (Shingles)

Herpes Zoster (Shingles) Vaccination

  • A single lifetime dose
  • Recommended for individuals over the age of 60 but can be given to those between the ages of 50-59
  • Vaccination results in a 50% reduction in herpes zoster (perhaps 40% in RA patients)
  • Vaccination results in a 66% reduction in post-herpetic neuralgia
  • Where possible give 4 weeks prior to the initiation of biologic therapy
  • Most would give this vaccine to patients receiving low dose prednisone (<20 mg/day).
  • There is less data but it may be given to patients on low dose immunosuppression such as low dose methotrexate (<0.4 mg/kg/week) or azathioprine (<3 mg/kg/day)
  • The effectiveness of this vaccine in patients who have had shingles is not known. Should be given 1 year after last shingles outbreak.